AI and CT scans could uncover silent heart threat in AF patients
NCT ID NCT07567508
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to find a hidden heart condition called cardiac amyloidosis in people with atrial fibrillation (AF). Researchers will use AI to analyze EKGs and CT scans to spot early signs of the disease. About 500 adults with AF and certain warning signs will be split into two groups: one gets the new screening plus usual AF care, the other gets usual care alone. The goal is to see if the screening catches more cases of cardiac amyloidosis over two years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung Medical Center
Seoul, Seoul, 06351, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- Could a smartphone alert replace daily blood thinners for AF?
- A carpal tunnel clue to a silent heart threat?
- Blood fat clues could flag hidden heart rhythm risk
- Heart scans may unlock hidden risks in minority communities
- Can a new heart ablation technique work without x-rays?